Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedNov 7, 2018MenoPowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0109-2019Class IITerminatedNov 7, 2018Woman PowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0108-2019Class IITerminatedNov 7, 2018Brain PowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0107-2019Class IITerminatedNov 7, 2018Man PowerCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0106-2019Class IITerminatedNov 7, 2018Rejuvenation PlusCGMP Deviations: products manufactured by contract manufacturer under conditions that could result in possible microbial contamination.Sprayology · D-0105-2019Class IITerminatedOct 31, 2018Bumetanide TabletsFailed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.Upsher Smith Laboratories, Inc. · D-0281-2019Class IITerminatedOct 31, 2018Bumetanide TabletsFailed impurities/ degradation specifications: Product is Out of Specification for an unspecified degradation product.Upsher Smith Laboratories, Inc. · D-0280-2019Class IIITerminatedOct 31, 2018Prednisolone and Gatifloxacin Ophthalmic SolutionPresence of precipitatePromise Pharmacy LLC · D-0239-2019Class IITerminatedOct 31, 2018Lidocaine 1% + Epinephrine 1:100Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.RXQ Compounding LLC · D-0130-2019Class IITerminatedOct 31, 2018Metoprolol Succinate Extended Release TabletsFailed dissolution specifications: Out-of-Specification dissolution test result obtained during routine stability testing.Teva Pharmaceuticals USA · D-0129-2019Class IITerminatedOct 31, 2018PIO&METFORMIN 15/1000 mg Tab 1Defective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0102-2019Class IITerminatedOct 31, 2018Metformin Hydrochloride Extended Release Tablets 1000 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0101-2019Class IITerminatedOct 31, 2018Metformin Hydrochloride Extended Release Tablets 1000 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0100-2019Class IITerminatedOct 31, 2018Metformin Hydrochloride Extended Release TabletsDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0099-2019Class IITerminatedOct 31, 2018FortametDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0098-2019Class IITerminatedOct 31, 2018Paliperidone Extended Release Tablets 9 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0097-2019Class IITerminatedOct 31, 2018Paliperidone Extended Release Tablets 3 mgDefective Delivery System: There is a potential for some tablets to be missing the laser drilling which might affect drug release.Teva Pharmaceuticals USA · D-0096-2019Class IITerminatedOct 31, 2018Meropenem for InjectionLack of assurance of sterility: loss of container integrity.Pfizer Inc. · D-0095-2019Class IITerminatedOct 31, 2018Cidofovir injection 375 mg/mLLack of Assurance of Sterility: complaints received about dried powder on the outside of the bottleHeritage Pharmaceuticals, Inc. · D-0094-2019Class IITerminatedOct 31, 2018Amlodipine/Valsartan HCTZ 10 mg/320 mg/25 mg tabletsCGMP Deviations: Detection of trace amounts of NDMA, a possible impurity or contaminant in an active pharmaceutical ingredient.RemedyRepack Inc. · D-0093-2019Class IITerminatedOct 31, 2018Fluocinolone Acetonide Topical SolutionFailed Impurities/Degradation Specifications:Out of specification result noticed for total impurities observed during stability analysisLupin Somerset · D-0092-2019Class IITerminatedOct 31, 2018Cyclosporine 1% Human Eye DropsLack of Process ControlsWestlab Pharmacy, Inc. dba Westlab Pharmacy · D-0091-2019Class IITerminatedOct 31, 2018ADAA Cataract DropsLack of Process ControlsWestlab Pharmacy, Inc. dba Westlab Pharmacy · D-0090-2019Class IITerminatedOct 31, 2018Alprostadil 500 mcg/mL InjectableIncorrect Product FormulationWestlab Pharmacy, Inc. dba Westlab Pharmacy · D-0089-2019Class IIITerminatedOct 31, 2018Testosterone Topical SolutionDefective Container: Repetitive complaints received indicating pump not working.Lupin Pharmaceuticals Inc. · D-0087-2019Class IITerminatedOct 31, 2018Cortaid 12-Hour Advanced Anti-itch CreamCGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No...Valeant Pharmaceuticals North America LLC · D-0086-2019Class IITerminatedOct 31, 2018Cortaid Maximum Strength CreamCGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No...Valeant Pharmaceuticals North America LLC · D-0085-2019Class IITerminatedOct 31, 2018Cortaid Intensive Therapy Cooling SprayCGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No...Valeant Pharmaceuticals North America LLC · D-0084-2019Class IITerminatedOct 31, 2018HydrOXYzine HYDROCHLORIDE SYRUPCGMP Deviations: cleaning procedures during manufacturing caused out of specification results for unknown impurities.Lannett Company, Inc. · D-0083-2019Class IIITerminatedOct 24, 2018Temozolomide capsulesFailed dissolution specifications: Out-of-Specification dissolution results obtained during stability testing.Amerigen Pharmaceuticals Inc. · D-0249-2019Class IITerminatedOct 24, 2018Clonazepam Orally Disintegrating Tablets USPFailed Stability Specifications: Out-of-specification test result for water content obtained during routine stability testing.Teva Pharmaceuticals USA · D-0082-2019Class IITerminatedOct 24, 2018Family Dollar Saline Nasal Spray 4.25 oz. canCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0080-2019Class IITerminatedOct 24, 2018Finafta BabyCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0079-2019Class IITerminatedOct 24, 2018Rexall, Extra Moisturizing No Drip Nasal SprayCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0078-2019Class IITerminatedOct 24, 2018Rexall, Extra Moisturizing No Drip Nasal SprayCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0077-2019Class IITerminatedOct 24, 2018Rexall, Sinus Nasal Pump MistCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0076-2019Class IITerminatedOct 24, 2018Rhinall Nasal Decongestant Nasal SprayCGMP Deviations: products manufactured under conditions that could impact its product quality.Product Quest Manufacturing LLC · D-0075-2019Class ITerminatedOct 24, 2018Sinus ReliefMicrobial Contamination of Non-Sterile Products: Failed microbiological testing for Pseudomonas aeruginosa.Product Quest Manufacturing LLC · D-0074-2019Class IITerminatedOct 24, 2018CVS HealthSubpotent Drug: low out of specification assay results for the bacitracin zinc ingredient.Product Quest Manufacturing LLC · D-0073-2019Class IITerminatedOct 24, 2018Mushatt's No. 9Microbial Contamination of Non-Sterile Products and Subpotent Drug: failure for microbiological growth exceeding specification and low out of specification assay results...Product Quest Manufacturing LLC · D-0072-2019